The estimated Net Worth of Michael Yurkowsky is at least $1.58 Milhão dollars as of 17 January 2020. Mr Yurkowsky owns over 25,000 units of H-CYTE stock worth over $1,531,207 and over the last 6 years he sold HCYT stock worth over $0. In addition, he makes $50,004 as CEO & Director at H-CYTE.
Sign up
Mr Yurkowsky HCYT stock SEC Form 4 insiders trading
Mr has made over 2 trades of the H-CYTE stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 25,000 units of HCYT stock worth $3,500 on 17 January 2020.
The largest trade he's ever made was buying 35,000 units of H-CYTE stock on 8 January 2019 worth over $4,550. On average, Mr trades about 15,000 units every 94 days since 2019. As of 17 January 2020 he still owns at least 1,531,207 units of H-CYTE stock.
You can see the complete history of Mr Yurkowsky stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Michael W. Yurkowsky biography
Michael W. Yurkowsky is the CEO & Director at H-CYTE.
What is the salary of Mr Yurkowsky?
As the CEO & Director of H-CYTE, the total compensation of Mr Yurkowsky at H-CYTE is $50,004. There are 4 executives at H-CYTE getting paid more, with William Horne having the highest compensation of $2,372,870.
How old is Mr Yurkowsky?
Mr Yurkowsky is 47, he's been the CEO & Director of H-CYTE since . There are 4 older and 4 younger executives at H-CYTE. The oldest executive at H-CYTE, Inc. is Raymond Monteleone, 72, who is the Director.
What's Mr Yurkowsky's mailing address?
Michael's mailing address filed with the SEC is 201 E KENNEDY BLVD,, SUITE 700, TAMPA,, FL, 33606.
Insiders trading at H-CYTE
Over the last 6 years, insiders at H-CYTE have traded over $0 worth of H-CYTE stock and bought 60,000 units worth $8,050 . The most active insiders traders include Todd Rfwhc Holdings, Llc Wa..., J Rex Iiifwhc Holdings, Llc..., eMichael Yurkowsky. On average, H-CYTE executives and independent directors trade stock every 286 days with the average trade being worth of $10,590,590. The most recent stock trade was executed by J Rex Iiifwhc Holdings, Llc... on 23 February 2022, trading 693,477 units of HCYT stock currently worth $6,935.
What does H-CYTE do?
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute biologics for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
What does H-CYTE's logo look like?
Complete history of Mr Yurkowsky stock trades at H-CYTE
H-CYTE executives and stock owners
H-CYTE executives and other stock owners filed with the SEC include:
-
William Horne,
Chairman of the Board -
Robert Greif,
Pres -
Jeremy Daniel,
Chief Financial Officer -
Jeremy Daniel,
Chief Financial Officer -
Michael W. Yurkowsky,
CEO & Director -
Michael Yurkowsky,
Director -
Raymond Monteleone,
Director -
Robert Greifas,
President, Chief Executive Officer -
Dr. Tanya Rhodes Ph.D.,
Chief Technology Officer -
Jeffery Wright CPA, CPA,
Controller & Principal Accounting Officer -
J Rex Iiifwhc Holdings, Llc...,
-
Todd Rfwhc Holdings, Llc Wa...,
-
Frederick Jcfrs Investments...,
-
Robert Smith Greif,
Chief Executive Officer -
Todd Rfwhc Bridge, Llc Wagner,